Chad Davis joined Morgan Lewis as a partner in its intellectual property practice in Boston, the firm announced Tuesday.
Davis counsels and implements patent strategies for biotech, pharmaceutical, and chemical companies on the development, protection, and commercialization of complex scientific innovations. He advises companies developing technologies including small molecule and biologic therapeutics, drug delivery platforms, antibodies, proteins, diagnostics, and advanced materials, the firm said.
He joins from Dechert.
This story was produced by Bloomberg Law Automation.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.